Altamira Therapeutics Ltd.
NasdaqCM:CYTO
$ 1.60
+ $0.16 (11.11%)
$ 1.60
+ $0.16 (11.11%)
End-of-day quote: 04/25/2024

CYTO - Altamira Therapeutics Stock Prediction 2025 - 2030

10 years of reliable Altamira Therapeutics stock forecast. The Wall Street analysts predict No Opinion for CYTO. See at a glance whether NasdaqCM:CYTO will rise in the future.

Forecast 2023
$1.86
Forecast 2025
$2.91
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
$1.86
Forecast 2030
$2.91
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
2.54
Price-to-book Ratio
0.37
Market Cap
0.00B
TEV
0.01 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$14.36
Country

Altamira Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Altamira Therapeutics Stock Forecast 2023

$7.50

In the last five quarters, Altamira Therapeutics’s Price Target has risen from $14.36 to $14.36 - a 0% increase.

368.75%
368.75
Last update: 04/26/2024

Highest Price Target $7.50

Average Price Target $7.50

Lowest Price Target $7.50

Altamira Therapeutics Stock Predictions 2025

Stock Forecast for the Price of an Altamira Therapeutics Share in Jan 2025.

In January 2025, analysts believe the stock price will be $1.72. An increase of 7.2% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Feb 2025.

In February 2025, analysts believe the stock price will be $1.73. An increase of 8.02% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Mar 2025.

In March 2025, analysts believe the stock price will be $1.74. An increase of 8.85% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Apr 2025.

In April 2025, analysts believe the stock price will be $1.75. An increase of 9.68% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in May 2025.

In May 2025, analysts believe the stock price will be $1.77. An increase of 10.51% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Jun 2025.

In June 2025, analysts believe the stock price will be $1.78. An increase of 11.34% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Jul 2025.

In July 2025, analysts believe the stock price will be $1.79. An increase of 12.17% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Aug 2025.

In August 2025, analysts believe the stock price will be $1.81. An increase of 13% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Sep 2025.

In September 2025, analysts believe the stock price will be $1.82. An increase of 13.83% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Oct 2025.

In October 2025, analysts believe the stock price will be $1.83. An increase of 14.66% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Nov 2025.

In November 2025, analysts believe the stock price will be $1.85. An increase of 15.49% compared to the previous month's estimate.

Stock Forecast for the Price of an Altamira Therapeutics Share in Dec 2025.

In December 2025, analysts believe the stock price will be $1.86. An increase of 16.32% compared to the previous month's estimate.

Altamira Therapeutics Stock Prediction 2030

Stock Prediction for the Price of One Altamira Therapeutics Share in Jan 2030.

In Jan 2030 analysts predict a share price of $2.68. An increase of 67.67% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Feb 2030.

In Feb 2030 analysts predict a share price of $2.70. An increase of 68.97% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Mar 2030.

In Mar 2030 analysts predict a share price of $2.72. An increase of 70.27% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Apr 2030.

In Apr 2030 analysts predict a share price of $2.75. An increase of 71.57% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in May 2030.

In May 2030 analysts predict a share price of $2.77. An increase of 72.87% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Jun 2030.

In Jun 2030 analysts predict a share price of $2.79. An increase of 74.16% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Jul 2030.

In Jul 2030 analysts predict a share price of $2.81. An increase of 75.46% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Aug 2030.

In Aug 2030 analysts predict a share price of $2.83. An increase of 76.76% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Sep 2030.

In Sep 2030 analysts predict a share price of $2.85. An increase of 78.06% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Oct 2030.

In Oct 2030 analysts predict a share price of $2.87. An increase of 79.35% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Nov 2030.

In Nov 2030 analysts predict a share price of $2.89. An increase of 80.65% compared to today's share price.

Stock Prediction for the Price of One Altamira Therapeutics Share in Dec 2030.

In Dec 2030 analysts predict a share price of $2.91. An increase of 81.95% compared to today's share price.

P/E
0.00
Beta
2.54
Price-to-book Ratio
0.37
Market Cap
0.00B
TEV
0.01 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$14.36
Country

Altamira Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Altamira Therapeutics Ltd.?

The following analysts have recently covered Altamira Therapeutics:

Diamond Equity Research LLC
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Altamira Therapeutics Ltd.?

The following sell-side analysts have recently covered Altamira Therapeutics:

Diamond, Hunter Louis
(This information refers to the last 90 days.)